This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panel
BMC Medical Genomics Open Access 15 January 2022
-
TET proteins and the control of cytosine demethylation in cancer
Genome Medicine Open Access 29 January 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tefferi A . Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 2010; 24: 1128–1138.
Kosmider O, Gelsi-Boyer V, Slama L, Dreyfus F, Beyne-Rauzy O, Quesnel B et al. Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. Leukemia 2010; 24: 1094–1096.
Chou WC, Huang HH, Hou HA, Chen CY, Tang JL, Yao M et al. Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations. Blood 2010; 116: 4086–4094.
Schaub FX, Looser R, Li S, Hao-Shen H, Lehmann T, Tichelli A et al. Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood 2010; 115: 2003–2007.
Khorashad JS, De Melo VA, Fiegler H, Gerrard G, Marin D, Apperley JF et al. Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis. Leukemia 2008; 22: 1806–1807.
Pardanani A, Lasho TL, Finke CM, Mai M, McClure RF, Tefferi A . IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms. Leukemia 2010; 24: 1146–1151.
Soverini S, Score J, Iacobucci I, Poerio A, Lonetti A, Gnani A et al. IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis. Leukemia 2011; 25: 178–181.
Boultwood J, Perry J, Zaman R, Fernandez-Santamaria C, Littlewood T, Kusec R et al. High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression. Leukemia 2010; 24: 1139–1145.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Roche-Lestienne, C., Marceau, A., Labis, E. et al. Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia. Leukemia 25, 1661–1664 (2011). https://doi.org/10.1038/leu.2011.139
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.139
This article is cited by
-
Genetic landscape of chronic myeloid leukemia
International Journal of Hematology (2023)
-
Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan
British Journal of Cancer (2023)
-
Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panel
BMC Medical Genomics (2022)
-
Low prevalence of the BCR–ABL1 fusion gene in a normal population in southern Sarawak
International Journal of Hematology (2020)
-
The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?
Current Hematologic Malignancy Reports (2019)